Gros David-Alexandre C has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 600000 shares of Eledon Pharmaceuticals, Inc. ($ELDN) on January 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 48,543,787 | 9999.99% | 1.24% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Restricted Stock Units | 66500 | $0.00 | 66,500.0000 | 48,543,787 | 9999.99% | 0.14% |
| Nov. 21, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Stock Option (right to buy) | 1015743 | $0.00 | 1,015,743.0000 | 51,945,920 | 9999.99% | 1.96% |
| June 13, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Stock Option (right to buy) | 517454 | $0.00 | 517,454.0000 | 24,619,197 | 9999.99% | 2.10% |
| May 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Common Stock (right to buy) | 383299 | $0.00 | 383,299.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Gros David-Alexandre C | Chief Executive Officer | A | Stock Option (right to buy) | 153600 | $0.00 | 153,600.0000 | 0 | 9999.99% | 0.00% |